[1] |
Ibrahem HM. B cell dysregulation in primary Sjögren's syndrome: A review[J]. Jpn Dent Sci Rev, 2019,55(1):139-144.
doi: 10.1016/j.jdsr.2019.09.006
URL
|
[2] |
Sebastian A, Misterska-Skora M, Silicki J, et al. Chest HRCT findings in patients with primary Sjogren's syndrome[J]. Adv Clin Exp Med, 2017,26(7):1101-1106.
doi: 10.17219/acem/68978
pmid: 29211358
|
[3] |
Gao H, Zhang XW, He J, et al. Prevalence, risk factors, and prognosis of interstitial lung disease in a large cohort of Chinese primary Sjögren syndrome patients: A case-control study[J]. Medicine (Baltimore), 2018,97(24):e11003.
doi: 10.1097/MD.0000000000011003
URL
|
[4] |
Flament T, Bigot A, Chaigne B, et al. Pulmonary manifestations of Sjogren's syndrome[J]. Eur Respir Rev, 2016,25(140):110-23.
doi: 10.1183/16000617.0011-2016
pmid: 27246587
|
[5] |
Gupta S, Ferrada MA, Hasni SA. Pulmonary manifestations of primary Sjogren's syndrome: Underlying immunological mechanisms, clinical presentation, and management[J]. Front Immunol, 2019,10:1327.
doi: 10.3389/fimmu.2019.01327
URL
|
[6] |
Heus A, Arends S, Van Nimwegen JF, et al. Pulmonary involvement in primary Sjögren's syndrome, as measured by the ESSDAI[J]. Scand J Rheumatol, 2020,49(1):38-46.
doi: 10.1080/03009742.2019.1634221
pmid: WOS:000488078900001
|
[7] |
Kampolis CF, Fragkioudaki S, Mavragani CP, et al. Prevalence and spectrum of symptomatic pulmonary involvement in primary Sjogren's syndrome[J]. Clin Exp Rheumatol, 2018, 36 Suppl 112(3): 94-101.
doi: <空>
pmid: WOS:000446486100014
|
[8] |
Schreiber K, Sciascia S, de Groot PG, et al. Antiphospholipid syndrome[J]. Nat Rev Dis Primers, 2018,4:17103.
doi: 10.1038/nrdp.2017.103
pmid: 29321641
|
[9] |
Mezhov V, Segan JD, Tran H, et al. Antiphospholipid syndrome: a clinical review[J]. Med J Aust, 2019,211(4):184-188.
doi: 10.5694/mja2.v211.4
URL
|
[10] |
Lee JJ, Pope JE. Pope.A meta-analysis of the risk of venous thromboembolism in inflammatory rheumatic diseases[J]. Arthritis Res Ther, 2014,16(5):435.
doi: 10.1186/s13075-014-0435-y
URL
|
[11] |
Chung WS, Lin CL, Sung FC, et al. Increased risks of deep vein thrombosis and pulmonary embolism in Sjogren syndrome: a nationwide cohort study[J]. J Rheumatol, 2014,41(5):909-915.
doi: 10.3899/jrheum.131345
URL
|
[12] |
Avina-Zubieta JA, Jansz M, Sayre EC, et al. The risk of deep venous thrombosis and pulmonary embolism in primary Sjogren syndrome: a general population-based study[J]. J Rheumatol, 2017,44(8):1184-1189.
doi: 10.3899/jrheum.160185
URL
|
[13] |
Ungprasert P, Srivali N, Kittanamongkolchai W. Risk of venous thromboembolism in patients with Sjogren's syndrome: a systematic review and meta-analysis[J]. Clin Exp Rheumatol, 2015,33(5):746-750.
pmid: 26087815
|
[14] |
Zhang YF, Lu YW. Clinical features of patients with primary Sjogren's syndrome complicated with venous thrombosis[J]. Zhonghua Yi Xue Za Zhi, 2018,98(39):3197-3199.
|
[15] |
Branchford BR, Carpenter SL. The Role of Inflammation in Venous Thromboembolism[J]. Front Pediatr, 2018,6:142.
doi: 10.3389/fped.2018.00142
pmid: 29876337
|
[16] |
Saghazadeh A, Hafizi S, Rezaei N. Inflammation in venous thromboembolism: Cause or consequence?[J]. Int Immunopharmacol, 2015,28(1):655-665.
doi: 10.1016/j.intimp.2015.07.044
URL
|
[17] |
Saghazadeh A, Rezaei N. VInflammation as a cause of venous thromboembolism[J]. Crit Rev Oncol Hematol, 2016,99:272-285.
doi: 10.1016/j.critrevonc.2016.01.007
URL
|
[18] |
Iba T, Levy JH. Inflammation and thrombosis: roles of neutrophils, platelets and endothelial cells and their interactions in thrombus formation during sepsis[J]. J Thromb Haemost, 2018,16(2):231-241.
doi: 10.1111/jth.13911
pmid: 29193703
|
[19] |
Olson NC, Cushman M, Lutsey PL, et al. Inflammation markers and incident venous thromboembolism: the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort[J]. J Thromb Haemost, 2014,12(12):1993-2001.
doi: 10.1111/jth.12742
pmid: 25292154
|
[20] |
Branchford BR, Carpenter SL. The Role of inflammation in venous thromboembolism[J]. Front Pediatr, 2018,6:142.
doi: 10.3389/fped.2018.00142
pmid: 29876337
|
[21] |
Baldini C, Zabotti A, Filipovic N, et al. Imaging in primary Sjögren's syndrome: the 'obsolete andthe new'[J]. Clin Exp Rheumatol, 2018, 36 Suppl 112(3): 215-221.
|
[22] |
Bjordal O, Norheim KB, Rødahl E, et al. Primary Sjögren's syndrome and the eye[J]. Surv Ophthalmol, 2020,65(2):119-132.
doi: 10.1016/j.survophthal.2019.10.004
URL
|
[23] |
Mavragani CP, Moutsopoulos HM. Sjögren's syndrome: Old and new therapeutic targets[J]. J Autoimmun, 2020,110:102364.
doi: 10.1016/j.jaut.2019.102364
URL
|